| C-reactive protein as a predictor of mild cognitive impairment conversion into Alzheimer's disease dementia A Fernandes, M Tábuas-Pereira, D Duro, M Lima, H Gens, B Santiago, ... Experimental gerontology 138, 111004, 2020 | 21 | 2020 |
| Neuropsychological profile of amyloid‐positive versus amyloid‐negative amnestic mild cognitive impairment L Alves, S Cardoso, D Silva, T Mendes, J Marôco, J Nogueira, M Lima, ... Journal of neuropsychology 15, 41-52, 2021 | 13 | 2021 |
| Can subjective memory complaints identify Aβ positive and Aβ negative amnestic mild cognitive impairment patients? T Mendes, S Cardoso, M Guerreiro, J Maroco, D Silva, L Alves, ... Journal of Alzheimer's Disease 70 (4), 1103-1111, 2019 | 12 | 2019 |
| Validation study of the Toulouse-Piéron cancellation test for Portuguese patients with mild cognitive impairment and alzheimer’s disease M Lima, D Duro, S Freitas, MR Simes, I Santana Sinapse 19 (1-2), 26-35, 2019 | 6 | 2019 |
| Neuropsychological features of progranulin-associated frontotemporal dementia: a nested case-control study M Lima, M Tábuas-Pereira, D Duro, J Durães, D Vieira, I Baldeiras, ... Neural Regeneration Research 16 (5), 910-915, 2021 | 4 | 2021 |
| Lower CSF Amyloid-Beta1–42 Predicts a Higher Mortality Rate in Frontotemporal Dementia D Vieira, J Durães, I Baldeiras, B Santiago, D Duro, M Lima, MJ Leitão, ... Diagnostics 9 (4), 162, 2019 | 4 | 2019 |
| Patients with progranulin mutations overlap with the progressive dysexecutive syndrome: towards the definition of a frontoparietal dementia phenotype M Tábuas-Pereira, MR Almeida, D Duro, M Lima, J Durães, R Guerreiro, ... Brain Communications 2 (2), fcaa126, 2020 | 3 | 2020 |
Miguel Tábuas PereiraCentro Hospitalar e Universitário de CoimbraVerified email at chuc.min-saude.pt
